These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3982246)

  • 1. False low antithrombin III results in renal disease.
    Fisher AH
    Med Lab Sci; 1985 Jan; 42(1):44-7. PubMed ID: 3982246
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis of increased thrombotic tendency with chromogenic substrates].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):135-41. PubMed ID: 6177594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of colorimetric, fluorometric and spectrophotometric methods for measuring antithrombin III using synthetic substrates].
    Uete T
    Rinsho Byori; 1984 Nov; 32(11):1258-62. PubMed ID: 6520982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assay of antithrombin III activity using chromogenic substrate (author's transl)].
    Koresawa S; Matsuda N; Ueda S
    Rinsho Byori; 1982 Jan; 30(1):54-8. PubMed ID: 7087231
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the determination of plasma antithrombin III with chromogenic peptide substrate (author's transl)].
    Nakamura S; Takizawa N; Nakanishi K; Igarashi M
    Rinsho Byori; 1980 Jan; 28(1):81-6. PubMed ID: 7373880
    [No Abstract]   [Full Text] [Related]  

  • 7. Methodological considerations on antithrombin determination.
    Abildgaard U
    Acta Chir Scand Suppl; 1982; 509():97-9. PubMed ID: 6962626
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of two-stage antithrombin III assay using new chromogenic peptide substrates (author's transl)].
    Asai K; Takagi A; Otsubo M
    Rinsho Byori; 1980 Jan; 28(1):76-80. PubMed ID: 7373879
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in antithrombin III values during and after extracorporeal circulation in heart surgery, measured on the day of operation using a chromogenic substrate and a laser nephelometer].
    Hopmeier P; Heuss F; Fischer M
    Wien Klin Wochenschr; 1984 Dec; 96(24):881-4. PubMed ID: 6528618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on tissue thromboplastic activity assay method with chromogenic substrates (S-2222)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1984 Mar; 32(3):313-6. PubMed ID: 6737742
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238.
    van Voorthuizen H; Kluft C
    Thromb Haemost; 1984 Dec; 52(3):350-3. PubMed ID: 6531759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antithrombin III assay using a chromogenic substrate in newborns].
    De Mattia D; Montagna O; Marvulli E
    Boll Soc Ital Biol Sper; 1979 Apr; 55(8):746-50. PubMed ID: 554643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automation of antithrombin III methods on routinely available instruments.
    Conard J
    Semin Thromb Hemost; 1983 Oct; 9(4):263-7. PubMed ID: 6658460
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombin-III: clinical significance.
    ten Cate JW
    Acta Chir Scand Suppl; 1982; 509():101-3. PubMed ID: 6962610
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the amidolytic method in the typing of congenital antithrombin III deficiency].
    Losonczy H; Nagy I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):184-8. PubMed ID: 6177603
    [No Abstract]   [Full Text] [Related]  

  • 18. [At II in liver diseases. Comparison between immunological determination and that with chromogenic substrate].
    Carmignoto F; Schivo P; Zotti S; Ceriotti G
    Arch Sci Med (Torino); 1980; 137(3):467-70. PubMed ID: 6786256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal pathology in the Ivory Coast: exploration and functional activity of antithrombin iii].
    Blavy G; Kouame C
    Nephrologie; 1994; 15(6):387-9. PubMed ID: 7862227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies on the determination of abnormal antithrombin III activity].
    Nagy I; Losonczy H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):180-3. PubMed ID: 6177602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.